BERARDICURTI, ONORINA
 Distribuzione geografica
Continente #
NA - Nord America 2.402
EU - Europa 1.155
AS - Asia 1.022
SA - Sud America 125
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 20
OC - Oceania 2
Totale 4.814
Nazione #
US - Stati Uniti d'America 2.346
SG - Singapore 476
RU - Federazione Russa 309
IT - Italia 281
IE - Irlanda 196
CN - Cina 192
VN - Vietnam 115
HK - Hong Kong 109
BR - Brasile 105
DE - Germania 89
SE - Svezia 61
GB - Regno Unito 54
FR - Francia 46
TR - Turchia 39
UA - Ucraina 37
FI - Finlandia 30
CA - Canada 26
BD - Bangladesh 23
IN - India 18
MX - Messico 9
NL - Olanda 9
AR - Argentina 8
PL - Polonia 8
ZA - Sudafrica 7
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
JP - Giappone 6
AT - Austria 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
ID - Indonesia 4
IQ - Iraq 4
JO - Giordania 4
LB - Libano 4
SN - Senegal 4
DZ - Algeria 3
EC - Ecuador 3
HR - Croazia 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
CR - Costa Rica 2
JM - Giamaica 2
KW - Kuwait 2
NP - Nepal 2
PK - Pakistan 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MQ - Martinica 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 4.727
Città #
Dallas 330
Chandler 285
Singapore 272
San Jose 242
Ashburn 229
Dublin 196
Jacksonville 157
Council Bluffs 129
Hong Kong 108
Santa Clara 84
New York 69
Boardman 59
The Dalles 51
Moscow 42
Milan 41
Los Angeles 40
Ho Chi Minh City 35
Beijing 34
L'aquila 30
Rome 30
Lawrence 28
Princeton 28
Wilmington 26
Izmir 21
Nanjing 21
Hanoi 20
Munich 19
L’Aquila 16
Lauterbourg 15
Orem 15
San Mateo 15
Hefei 14
Washington 14
Helsinki 13
São Paulo 13
Chicago 12
Columbus 12
Ann Arbor 11
Naples 11
Phoenix 11
Dearborn 10
Des Moines 10
Falkenstein 10
Montreal 10
Seattle 10
Shanghai 10
Woodbridge 10
Kitzingen 9
Stockholm 9
Assago 8
Mountain View 8
Frankfurt am Main 7
London 7
Verona 7
Warsaw 7
Brno 6
Brooklyn 6
Brussels 6
Denver 6
Dong Ket 6
Houston 6
Johannesburg 6
Nanchang 6
Chennai 5
Da Nang 5
Lappeenranta 5
Manchester 5
Ningbo 5
Paris 5
Poplar 5
Shenyang 5
Tokyo 5
Amman 4
Amsterdam 4
Atlanta 4
Bologna 4
Brasília 4
Dakar 4
Genoa 4
Hangzhou 4
Jiaxing 4
Mexico City 4
Nuremberg 4
Pune 4
Turin 4
Vienna 4
Ankara 3
Bari 3
Belo Horizonte 3
Boston 3
Bremen 3
Catania 3
Cleveland 3
Düsseldorf 3
Edinburgh 3
Florence 3
Grafing 3
Guangzhou 3
Haiphong 3
Hebei 3
Totale 3.121
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 195
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 185
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 168
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 167
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 164
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 155
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 155
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 152
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 151
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 145
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 142
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 141
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 140
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 136
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 136
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 135
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 134
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 132
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 130
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry 129
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 127
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 127
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 126
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 124
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 124
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 124
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 123
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 122
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 119
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 118
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 116
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 106
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 106
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 105
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 103
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives 52
Totale 4.814
Categoria #
all - tutte 20.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022129 0 0 0 9 2 4 0 5 11 22 15 61
2022/2023666 57 54 17 96 37 73 0 39 249 3 27 14
2023/2024214 30 4 14 11 19 66 1 15 3 5 16 30
2024/2025810 33 13 51 52 105 66 97 58 163 63 55 54
2025/20261.892 112 172 235 195 181 116 261 45 143 273 132 27
2026/2027494 39 38 154 263 0 0 0 0 0 0 0 0
Totale 4.814